Letters

LETTERS Date: May 30, 1988 Too Many Papers I would like to express my enthusiastic agreement with the letter from Jeanne F. Loring (May 2, 1988, p. 9). All my colleagues and I are troubled by the rapidly increasing number of articles we’d like to read. As Loring points out, simply scanning the titles of potentially interesting articles in potentially interesting journals can no longer be done in a satisfactory way. Like Loring, I know scientists who publish 50 or more (in some cases over

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LETTERS Date: May 30, 1988

Too Many Papers I would like to express my enthusiastic agreement with the letter from Jeanne F. Loring (May 2, 1988, p. 9). All my colleagues and I are troubled by the rapidly increasing number of articles we’d like to read. As Loring points out, simply scanning the titles of potentially interesting articles in potentially interesting journals can no longer be done in a satisfactory way.

Like Loring, I know scientists who publish 50 or more (in some cases over 100) articles per year. Can you imagine that? An article every other day! While Loring’s proposed limit of three articles per year may be a bit on the low side, it seems to me that the concept of a limit is a useful one. Perhaps the granting agencies could emphasize in their guidelines that publication quality as well as quantity is important in evaluating grant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies